Ewa Augustin
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Cancer therapeutics and mechanisms 17
- Advanced biosensing and bioanalysis techniques 6
- Oncology 16
- Drug Transport and Resistance Mechanisms 6
- Lung Cancer Research Studies 4
- Cancer Cells and Metastasis 3
- Co-authors
- Zofia Mazerska (17 shared papers)Jerzy Konopa (10 shared papers)Anna Skwarska (8 shared papers)Robert Tylingo (5 shared papers)Anna M. Nowicka (8 shared papers)Piotr Szweda (1 shared paper)Agata Kowalczyk (7 shared papers)M Sadowska (1 shared paper)
- Journals
- Biochemical Pharmacology (6 papers)International Journal of Molecular Sciences (6 papers)Molecules (3 papers)Acta Pharmacologica Sinica (3 papers)Toxicology in Vitro (2 papers)
- Partner nations
- PolandUnited StatesUnited Kingdom
In The Last Decade
Ewa Augustin
46 papers receiving 996 citations
Peers
Comparison fields: 5 of 105
- Toxicology 68
- Biomaterials 203
- Molecular Medicine 55
- Pharmacology 95
- Pharmaceutical Science 46
Countries citing papers authored by Ewa Augustin
This map shows the geographic impact of Ewa Augustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Augustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Augustin more than expected).
Fields of papers citing papers by Ewa Augustin
This network shows the impact of papers produced by Ewa Augustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Augustin. The network helps show where Ewa Augustin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ewa Augustin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 130 | |
| 2 | 2012 | 80 | |
| 3 | 2016 | 77 | |
| 4 | 2013 | 43 | |
| 5 | 2015 | 39 | |
| 6 | 2007 | 39 | |
| 7 | 2013 | 36 | |
| 8 | 2006 | 34 | |
| 9 | 2016 | 34 | |
| 10 | 2020 | 33 | |
| 11 | 1996 | 29 | |
| 12 | 2020 | 27 | |
| 13 | 2013 | 27 | |
| 14 | 2022 | 24 | |
| 15 | 2009 | 23 | |
| 16 | 2023 | 22 | |
| 17 | QSAR of acridines, III. Structure-activity relationship for antitumour imidazoacridinones and intercorrelations between in vivo and in vitro tests. | 1996 | 22 |
| 18 | 2021 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2012 | 16 |
About Ewa Augustin
Ewa Augustin is a scholar working on Molecular Biology, Oncology, Biomaterials, Pharmacology and Materials Chemistry, having authored 48 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Nanocomposite Films for Food Packaging (4 papers), Lung Cancer Research Studies (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Toxicology (68 citations), Biomaterials (203 citations), Molecular Medicine (55 citations), Pharmacology (95 citations) and Pharmaceutical Science (46 citations). Ewa Augustin has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Zofia Mazerska, Jerzy Konopa, Anna Skwarska, Robert Tylingo, Anna M. Nowicka, Piotr Szweda, Agata Kowalczyk, M Sadowska, Grzegorz Gorczyca and Sławomir Milewski. Their work appears in journals such as Biochemical Pharmacology, International Journal of Molecular Sciences, Molecules, Acta Pharmacologica Sinica and Toxicology in Vitro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.